Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Reminyl
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Reminyl XL 24mg capsules
0411000F0BBAHAG
|
Reminyl | Galantamine | Central Nervous System | 119 |
|
Reminyl 4mg/ml oral solution
0411000F0BBAEAD
|
Reminyl | Galantamine | Central Nervous System | 62 |
|
Reminyl XL 16mg capsules
0411000F0BBAGAF
|
Reminyl | Galantamine | Central Nervous System | 33 |
|
Reminyl XL 8mg capsules
0411000F0BBAFAE
|
Reminyl | Galantamine | Central Nervous System | 28 |
|
Reminyl 12mg tablets
0411000F0BBACAC
|
Reminyl | Galantamine | Central Nervous System | No data available |
|
Reminyl 4mg tablets
0411000F0BBAAAA
|
Reminyl | Galantamine | Central Nervous System | No data available |
|
Reminyl 8mg tablets
0411000F0BBABAB
|
Reminyl | Galantamine | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.